Civco Medical Solutions trUpoint ARCH Protura ESTRO Forum

April 15, 2013 — Civco Medical Solutionswill showcase trUpoint Arch, a new stereotactic radiosurgery solution, Protura Robotic Patient Positioning System, and the Universal Couchtop Long Extension, along  with other disease site solutions at the 2nd ESTRO Forum, booth #5200 in Geneva, Switzerland, April 19 to 23 2013.

trUpoint ARCH — CIVCO’s new SRS/SRT solution for head and brain disease sites provides clinicians a simple and manageable patient set-up assuring accuracy and repeatability during treatments. The frameless bridge design effectively stabilizes a patient’s head in a non-invasive, comfortable hold for delivering high radiation doses. Compatible with the Universal Couchtop, Posifix thermoplastic system, AccuForm cushions and Protura Robotic Patient Positioning System, trUpoint Arch provides a comprehensive motion management solution for effective SRS/SRT treatment.

Universal Couchtop Long Extension — The Universal Couchtop Long Extension (UCT LE) facilitates better delivery of dose and target coverage by eliminating the interference of rails and junctions with radiation delivery.[1] The robust and durable UCT LE features a large junction-free and artifact-free treatment area. All four extension options attach and detach with ease. UCT LE allows a more efficient workflow with seamless transition from simulation to treatment provided by dosimetrically matching couchtops. Additionally, the unique profile of the UCT LE allows CIVCO’s SBRT Body Pro-Lok bridges to attach directly to the couchtop, enabling a seamlessly integrated SBRT immobilization platform.

Protura Robotic Patient Positioning System — The Protura system is designed to integrate with existing IGRT solutions and Linac. The system positions the patient with 6 degrees of freedom from outside the treatment room, enabling more accurate treatment and keeps patient positioning and motion management on target.  Protura provides the platform to provide a comprehensive motion management solution for every disease site.

For more information: www.CIVCO.com

[1] Physics in Medicine and Biology, December 7, 2011, Vol 56:23, pp. 7435-7447.


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | ASTRO

Sept. 10, 2025 — ZAP Surgical Systems, Inc. will make its debut at the 2025 ASTRO (American Society for Radiation ...

Time September 12, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
Subscribe Now